Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Trxade Group Inc. (MEDS)

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report

Posted on April 30, 2020 by MissionIR

Trxade Group (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We are initiating coverage of Trxade with a Buy rating and Price Target of $12. MEDS’ primary offering is … Continue reading →

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Engagement of MZ Group to Expand Strategic Communications Program Across Key Markets

Posted on April 28, 2020 by MissionIR

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced its engagement of international investor relations specialists MZ Group (“MZ”) to expand its comprehensive strategic investor relations and financial communications program across all key markets. … Continue reading →

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Enters First Agreement to Supply COVID-19 Testing Kits

Posted on April 27, 2020 by MissionIR

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced entry into its first Covid-19 antibody testing kits supply agreement with law firm McIntyre Thanasides Bringgold Elliott Grimaldi Guito & Matthews, P.A. According to the … Continue reading →

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Enabling Patients to Access Physicians from Home

Posted on April 17, 2020 by MissionIR

Trxade Group’s (NASDAQ: MEDS) wholly owned subsidiary Bonum Health is a virtual telehealth provider that is helping patients to simply and affordably access board-certified physicians and receive medical prescriptions from the comfort of their homes. A recent article discussing the … Continue reading →

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

Trxade Group Inc.’s (NASDAQ: MEDS) E-Commerce Platform Targeting Independent Pharmacy Market of Over $78 Billion a Year

Posted on April 13, 2020 by MissionIR

Company boasts significant first-mover advantage in proprietary web-based e-commerce platform segment Revenue growth driven by increases in the number of registered users and acquisition of Pharmacy Currently adding 100+ pharmacies per month to its online purchasing platform Trxade seeking FDA … Continue reading →

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Reaches Thousands of Independent Pharmacies with e-Commerce Platform

Posted on April 9, 2020 by MissionIR

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, has more than 12,100 pharmacies currently registered as users of its proprietary Supplier-to-Pharmacy (“S2P”) … Continue reading →

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

Trxade Group Inc. (NASDAQ: MEDS) Reports Revenue Growth Amid Buildup to Multi-Platform Telehealth Integration

Posted on April 8, 2020 by MissionIR

Trxade Group Inc. is an expanding healthcare tech platform builder that aims to assist small, community-based pharmaceutical businesses and the patients who comprise their customers through drug pricing and delivery operations as well as telemedicine consultations Trxade Group recently announced … Continue reading →

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Hold 2020 Annual Meeting of Stockholders on May 29

Posted on April 3, 2020 by MissionIR

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, on Thursday announced that it will be holding its 2020 Annual Meeting of Stockholders at its corporate offices in Land O’ Lakes, Florida on Friday, May 29, 2020 … Continue reading →

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Bonum Health Offers Key Technology in Fight Against Coronavirus

Posted on April 2, 2020 by MissionIR

Trxade Group’s wholly owned subsidiary, Bonum Health, allows patients to access medical advice from the comfort of their homes Telemedicine is getting its moment in the clinical spotlight as COVID-19 contagion fears are being addressed by limiting face-to-face human interaction … Continue reading →

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Integra Pharma Solutions Files for FDA Emergency Use Authorization for Rapid COVID-19 Test Kit

Posted on April 1, 2020 by MissionIR

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that its wholly-owned subsidiary, Integra Pharma Solutions, has filed for an Emergency Use Authorization (“EUA”) with the U.S. Food and Drug Administration (“FDA”) in collaboration … Continue reading →

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment